Management of patients on non–vitamin K antagonist oral anticoagulants in the acute care and periprocedural setting: a scientific statement from the American Heart …
AN Raval, JE Cigarroa, MK Chung, LJ Diaz-Sandoval… - Circulation, 2017 - Am Heart Assoc
Non–vitamin K oral anticoagulants (NOACs) are now widely used as alternatives to warfarin
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
Management of patients on Non-Vitamin K antagonist oral anticoagulants in the acute care and periprocedural setting
AN Raval, JE Cigarroa, MK Chung… - Circulation, 2017 - profiles.wustl.edu
Non-Vitamin K oral anticoagulants (NOACs) are now widely used as alternatives to warfarin
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American …
AN Raval, JE Cigarroa, MK Chung, LJ Diaz-Sandoval… - Circulation, 2017 - europepmc.org
Non–vitamin K oral anticoagulants (NOACs) are now widely used as alternatives to warfarin
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
Management of patients on Non-Vitamin K antagonist oral anticoagulants in the acute care and periprocedural setting
AN Raval, JE Cigarroa, MK Chung… - …, 2017 - ohsu.elsevierpure.com
Non-Vitamin K oral anticoagulants (NOACs) are now widely used as alternatives to warfarin
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American …
AN Raval, JE Cigarroa, MK Chung… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Non-vitamin K oral anticoagulants (NOACs) are now widely used as alternatives to warfarin
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
Management of patients on Non-Vitamin K antagonist oral anticoagulants in the acute care and periprocedural setting
Council on Cardiovascular Disease in … - …, 2017 - utsouthwestern.elsevierpure.com
Non-Vitamin K oral anticoagulants (NOACs) are now widely used as alternatives to warfarin
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American …
AN Raval, JE Cigarroa, MK Chung, LJ Diaz-Sandoval… - Circulation, 2017 - cir.nii.ac.jp
抄録< jats: p> Non–vitamin K oral anticoagulants (NOACs) are now widely used as
alternatives to warfarin for stroke prevention in atrial fibrillation and management of venous …
alternatives to warfarin for stroke prevention in atrial fibrillation and management of venous …
[HTML][HTML] Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the …
AN Raval, JE Cigarroa, MK Chung, LJ Diaz-Sandoval… - Circulation, 2017 - ncbi.nlm.nih.gov
Non–vitamin K oral anticoagulants (NOACs) are now widely used as alternatives to warfarin
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …
for stroke prevention in atrial fibrillation and management of venous thromboembolism. In …